Health Team
Chapel Hill pharmaceutical company developing drug to reduce fatal overdoses
Chapel Hill-based Cessation Therapeutics says its monoclonal antibody therapy, CSX-1004, can block the dangerous effects of fentanyl.
Details
Transcript
Chapel Hill-based Cessation Therapeutics says its monoclonal antibody therapy, CSX-1004, can block the dangerous effects of fentanyl.
Reporter : Shelle JacksonPhotographer : Rick Armstrong
Web Editor : Ryan Bisesi
Posted 2023-11-07T17:32:31-0500 - Updated 2023-11-07T17:32:31-0500
